Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Revenue

In the year 2025, Neimeth International Pharmaceuticals had annual revenue of 7.37B NGN with 64.29% growth. Neimeth International Pharmaceuticals had revenue of 2.36B in the quarter ending December 31, 2025, with 69.59% growth.

• Revenue: 7.37B
• Revenue Growth: +64.29%
• P/S Ratio: 7.31
• Revenue / Employee: 42.11M
• Employees: 175
• Market Cap: 53.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.37B	2.88B	64.29%
Dec 31, 2024	4.49B	2.28B	102.98%
Dec 31, 2023	2.21B	-709.73M	-24.31%
Dec 31, 2022	2.92B	216.47M	8.01%
Sep 30, 2022	2.70B	-343.81M	-11.28%